FIRST AIRED: May 30, 2015

Nice work! Enjoy the show!

×

You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!

×

Transcript

00:00:00
most important vance is in cancer research and tens of thousands of oncologists and health care professionals descending on chicago this weekend to see new major breakthroughs in cancer treatment , reuters pharmaceuticals correspondent bill burke right is covering the american society of clinical oncology conference the big excitement at this cancer meeting and and in cancer in general is are these so called me you know farrah uses a new wave of drugs that , that basically help the body's own immune system to attack cancerous and tumors and they've been there are proven to be highly effective in our couple cups of cancer so far especially melanoma and lung cancer at this meeting we're going to see how they work and a whole host of other cancers ergoride says the new drugs called p. d. one inhibitors from american bristol myers squibb are huge advancements in the fight against cancer but they come with a hefty price tag , okay true to and and bristles up devo each cost about a hundred fifty thousand dollars a year but they're also gonna remarkable scientific breakthroughs and it's hard to deny you know patients who have no other options a drug that could actually help the live longer meeting wraps up on tuesday but burke right says the new drugs and data presented over the course of the conference , will without question have people talking long after it's over